A new study found that GLP-1 weight loss drugs including Mounjaro, Ozempic, and Wegovy are linked to increased risk of hair loss, though the absolute risk remains low. The risk of alopecia for GLP-1 users is significantly higher than for people taking other diabetes medications.
No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.
Weight loss drugs such as Mounjaro, Ozempic and Wegovy are linked to an increased risk of hair loss, according to researchers.
Weight loss and diabetes drugs like Mounjaro, Ozempic and Wegovy are linked to an increased risk of hair loss, according to researchers.
People on GLP-1 agonist drugs such as Mounjaro, Ozempic and Wegovy have been reporting hair loss
People taking GLP-1 drugs have a low risk of hair loss, which is significantly higher than for those on other diabetes medications, a new study has found.
New Study Links GLP-1s to Hair Loss😰 — Absolute risk of alopecia was low, however www.medpagetoday.com/endocrinolog... Absolute risk of alopecia was low, however
www.euronews.com/health/2026/... People taking GLP-1 drugs have a low risk of hair loss, which is significantly higher than for those on other diabetes medications, a new study has found.
Hair Loss May Be a New Potential Side Effect of GLP-1 Weight Loss Drugs www.discovermagazine.com/hair-loss-ma... After people reported hair loss when using a GLP-1 drug, researchers confirmed this side effect by comparing it to other type 2 diabetes drugs.
New studies reveal rare but real risk of GLP-1 drugs https://www.europesays.com/us/958293/ July 22 (Reuters) – The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes,…#us #news #usnews The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest.